Alvogen Korea Overview

  • Year Founded
  • 1958

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 605

Employees

  • Latest Deal Type
  • Corporate

  • Financing Rounds
  • 3

Alvogen Korea General Information

Description

Manufacturer of pharmaceutical products based in Seoul, South Korea. The company offers treatment of conditions in the areas of oncology, cardiology, respiratory, neurology and gastroenterology, thereby ensuring affordable generic medications that help reduce healthcare costs around the world.

Contact Information

Formerly Known As
Kunwha Pharmaceuticals
Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Formerly PE-Backed
Corporate Office
  • 5th floor
  • GT Tower, 411 Seocho-daero
  • Seoul, Seocho-gu 06615
  • South Korea
+82
Primary Industry
Pharmaceuticals
Parent Company
Corporate Office
  • 5th floor
  • GT Tower, 411 Seocho-daero
  • Seoul, Seocho-gu 06615
  • South Korea
+82

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Alvogen Korea Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Alvogen Korea‘s full profile, request access.

Request a free trial

Alvogen Korea Patents

Alvogen Korea Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2021069944-A1 Pharmaceutical composition comprising mirabegron and process for manufacturing the same Inactive 09-Oct-2019
WO-2019235898-A1 Combined preparation containing bazedoxifene and vitamin d Inactive 08-Jun-2018
WO-2018199636-A1 A combination formulation comprising hmg-coa reductase inhibitor and calcium channel blocker Inactive 26-Apr-2017
EP-3090744-A1 Pharmaceutical complex formulation comprising angiotensin ii receptor blocker and hmg-coa reductase inhibitor Active 30-Dec-2013
EP-3090744-A4 Pharmaceutical complex formulation comprising angiotensin ii receptor blocker and hmg-coa reductase inhibitor Active 30-Dec-2013 A61K31/41
To view Alvogen Korea’s complete patent history, request access »

Alvogen Korea Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Alvogen Korea FAQs

  • When was Alvogen Korea founded?

    Alvogen Korea was founded in 1958.

  • Where is Alvogen Korea headquartered?

    Alvogen Korea is headquartered in Seoul, South Korea.

  • What is the size of Alvogen Korea?

    Alvogen Korea has 605 total employees.

  • What industry is Alvogen Korea in?

    Alvogen Korea’s primary industry is Pharmaceuticals.

  • Is Alvogen Korea a private or public company?

    Alvogen Korea is a Private company.

  • What is Alvogen Korea’s current revenue?

    The current revenue for Alvogen Korea is .

  • When was Alvogen Korea acquired?

    Alvogen Korea was acquired on 15-Feb-2019.

  • Who acquired Alvogen Korea?

    Alvogen Korea was acquired by Alvogen Group.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process